LCG
PCRX icon

Lisanti Capital Growth’s Pacira BioSciences PCRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-138,830
Closed -$3.97M 141
2024
Q2
$3.97M Buy
+138,830
New +$3.97M 0.95% 50
2022
Q3
Sell
-130,873
Closed -$7.63M 130
2022
Q2
$7.63M Sell
130,873
-171,540
-57% -$10M 1.04% 37
2022
Q1
$23.1M Buy
302,413
+178,428
+144% +$13.6M 2.59% 3
2021
Q4
$7.46M Buy
123,985
+92,060
+288% +$5.54M 1.08% 33
2021
Q3
$1.79M Buy
31,925
+10,560
+49% +$591K 0.26% 120
2021
Q2
$1.3M Sell
21,365
-161,740
-88% -$9.81M 0.16% 127
2021
Q1
$12.8M Buy
+183,105
New +$12.8M 1.65% 12
2020
Q4
Sell
-168,482
Closed -$10.1M 139
2020
Q3
$10.1M Buy
168,482
+94
+0.1% +$5.65K 1.88% 7
2020
Q2
$8.84M Buy
168,388
+59,709
+55% +$3.13M 1.8% 7
2020
Q1
$3.64M Buy
108,679
+5,530
+5% +$185K 1.2% 30
2019
Q4
$4.67M Buy
103,149
+7,779
+8% +$352K 1.24% 33
2019
Q3
$3.63M Sell
95,370
-23,250
-20% -$885K 1.18% 34
2019
Q2
$5.16M Buy
118,620
+46,615
+65% +$2.03M 1.68% 20
2019
Q1
$2.74M Sell
72,005
-31,185
-30% -$1.19M 0.97% 41
2018
Q4
$4.44M Buy
103,190
+42,575
+70% +$1.83M 1.79% 15
2018
Q3
$2.98M Buy
+60,615
New +$2.98M 1.03% 44
2017
Q3
Sell
-16,700
Closed -$797K 124
2017
Q2
$797K Buy
16,700
+6,380
+62% +$304K 0.53% 84
2017
Q1
$471K Buy
+10,320
New +$471K 0.67% 75
2016
Q1
Sell
-24,035
Closed -$1.85M 107
2015
Q4
$1.85M Buy
+24,035
New +$1.85M 1.94% 6
2014
Q4
Sell
-48,280
Closed -$4.68M 101
2014
Q3
$4.68M Sell
48,280
-2,250
-4% -$218K 2.35% 2
2014
Q2
$4.64M Sell
50,530
-835
-2% -$76.7K 2.08% 4
2014
Q1
$3.6M Sell
51,365
-630
-1% -$44.1K 1.55% 15
2013
Q4
$2.99M Sell
51,995
-19,765
-28% -$1.14M 1.26% 26
2013
Q3
$3.45M Buy
71,760
+41,725
+139% +$2.01M 1.57% 17
2013
Q2
$1.02M Buy
+30,035
New +$1.02M 0.49% 79